Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
Saved in:
| Title: | Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis. |
|---|---|
| Authors: | Makaro, Adam1 (AUTHOR), Świerczyński, Mikołaj1 (AUTHOR), Pokora, Kacper1 (AUTHOR), Sarniak, Barbara1 (AUTHOR), Kordek, Radzisław2 (AUTHOR), Fichna, Jakub1 (AUTHOR), Salaga, Maciej1 (AUTHOR) salaga.maciej@gmail.com |
| Source: | Inflammopharmacology. Feb2024, Vol. 32 Issue 1, p377-392. 16p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
